346 related articles for article (PubMed ID: 9767644)
1. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Sugimoto T; Shimazaki Y; Manaka A; Tanikawa T; Suzuki K; Nanaumi K; Kaneda Y; Yamasaki Y; Sugiyama H
Bioorg Med Chem Lett; 2012 Sep; 22(17):5739-43. PubMed ID: 22858102
[TBL] [Abstract][Full Text] [Related]
3. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of 6-O-heteroarylcarbamoyl-11,12-lactoketolides.
Grant EB; Guiadeen D; Abbanat D; Foleno BD; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2006 Apr; 16(7):1929-33. PubMed ID: 16446089
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Burger MT; Lin X; Chu DT; Hiebert C; Rico AC; Seid M; Carroll GL; Barker L; Huh K; Langhorne M; Shawar R; Kidney J; Young K; Anderson S; Desai MC; Plattner JJ
J Med Chem; 2006 Mar; 49(5):1730-43. PubMed ID: 16509588
[TBL] [Abstract][Full Text] [Related]
7. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
Pavlović D; Fajdetić A; Mutak S
Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A
J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
[TBL] [Abstract][Full Text] [Related]
10. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
[TBL] [Abstract][Full Text] [Related]
11. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
Felmingham D
J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of a novel class of 4'-substituted 16-membered ring macrolides derived from tylosin.
Phan LT; Jian T; Chen Z; Qiu YL; Wang Z; Beach T; Polemeropoulos A; Or YS
J Med Chem; 2004 Jun; 47(12):2965-8. PubMed ID: 15163176
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.
Keyes RF; Carter JJ; Englund EE; Daly MM; Stone GG; Nilius AM; Ma Z
J Med Chem; 2003 May; 46(10):1795-8. PubMed ID: 12723941
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.
Agouridas C; Bonnefoy A; Chantot JF
Antimicrob Agents Chemother; 1997 Oct; 41(10):2149-58. PubMed ID: 9333040
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
[TBL] [Abstract][Full Text] [Related]
17. A simple method for deprotection of the N- and O-carbobenzoxy groups and N-methylation of the desosamine sugar moiety of ketolides. Application to the synthesis of ketolide analogues with various 9-iminoether moieties and their antibacterial activities.
Iwaki T; Nomura T; Narukawa Y; Uotani K
J Antibiot (Tokyo); 2005 Nov; 58(11):679-85. PubMed ID: 16466021
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
19. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens.
Nomura T; Yasukata T; Narukawa Y; Uotani K
Bioorg Med Chem; 2005 Nov; 13(21):6054-63. PubMed ID: 15994088
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
